Thu. 2 May 2024, 5:52pm ET
Benzinga
Earnings, Earnings Beats, News
Relay Therapeutics (NASDAQ:RLAY) reported quarterly losses of $(0.62) per share which beat the analyst consensus estimate of $(0.71) by 12.68 percent. This is a 20.51 percent increase over losses of $(0.78) per share from the same period last year. The company reported quarterly sales of $10.007 million which beat the analyst consensus estimate of $87.500 thousand by 11.34K percent. This is a 4.33K percent increase over sales of $226.000 thousand the same period last year.